A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction

Summary

The primary objective is to explore if HRS8179 could improve midline shift at 72 hours (or at time of decompressive craniectomy or comfort measures only, if earlier) in participants with large hemispheric infarction. The secondary objective is to explore if HRS8179 could improve acute neurologic status, functional outcomes, treatment requirements and safety.

Timeline

Start

2023-04-07

Primary completion

2023-12-05

Completion

2024-02-27

Drugs

Indications